高盛发布研报称，对中国人寿（02628）评级为中性，基于总资产回报率计算的12个月目标价为28.5港元，对应1.0倍的2027年预期市净率。投资者问题主要集中于销售前景、银保渠道的潜在增长和干扰情况、投资及股息方面。中国人寿重申2026年的目标是实现新业务价值两位数增长，并强调了银保渠道的竞争优势。2026年二季度股市的强劲走势已推动投资表现改善。对于担忧三季度基数效应的投资者，中国人寿表示应该关注全年利润，尤其是考虑到四季度较低的基数。管理层还将努力降低每股股息的波动幅度。
责任编辑：卢昱君
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.